Skip to main content
. Author manuscript; available in PMC: 2016 Feb 26.
Published in final edited form as: ACS Appl Mater Interfaces. 2015 Sep 29;7(40):22272–22276. doi: 10.1021/acsami.5b05393

Figure 3.

Figure 3

Representative 3D maximum intensity projection images (T1-weighted) of Balb/c mice injected with Gd3+-DOTA-HPCD (top row) or Gd3+-DOTA-HPCD/Pluronic PR (bottom row) at a 0.03 mM-Gd/kg dose. Images are shown for contrast agent distribution before injection (pre) and at 5, 15 and 30 min after tail vein injection of Gd3+ complexes.